Loading...
Loading...
Application UK00914958607 · Registered

| Application Number | UK00914958607 |
| Status | Registered |
| Owner | Bristol-Myers Squibb Company |
| Filed | 2015-12-24 |
| Registered | 2016-07-01 |
| Renewal Due | 2035-12-24 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. upl Universal Patient Language is currently a registered UK trademark, with renewal due on 2035-12-24. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Computer application software for mobile devices, namely, software for recording and generating health and medical information and reports all in the field of the field of pharmaceutical preparations for human use.
Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for human use.
Educational services related to a patient support program; providing a website featuring educational information in the field of pharmaceutical preparations for human use.
Health care services, namely, providing information to physicians, health care professionals and patients in the field of pharmaceutical preparations for human use.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'upl Universal Patient Language' is a registered trademark on the UK IPO register, owned by Bristol-Myers Squibb Company. The application (UK00914958607) was filed on 24 December 2015 and registered on 1 July 2016. The registration is set to expire on 24 December 2035.
This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 16 (paper, cardboard & printed matter); Class 41 (education, entertainment & sporting services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Sipara Limited.
UK trademark UK00914958607 for the mark 'upl Universal Patient Language' in Class 9, 16, 41, 44 is recorded on the UK IPO register as owned by Bristol-Myers Squibb Company. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00914958607 for the mark 'upl Universal Patient Language' as registered.
UK trademark UK00914958607 for the mark 'upl Universal Patient Language' is recorded in Class 9 (scientific, electrical & IT apparatus); Class 16 (paper, cardboard & printed matter); Class 41 (education, entertainment & sporting services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 9: Computer application software for mobile devices, namely, software for recording and generating health and medical information and reports all in the field of the field of pharmaceutical preparations for human use. | Class 16: Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newslet…
UK trademark UK00914958607 for the mark 'upl Universal Patient Language' was filed at the UK IPO on 24 December 2015 and registered on 1 July 2016.
UK trademark UK00914958607 for the mark 'upl Universal Patient Language' is currently recorded as valid until 24 December 2035, at which point it will need to be renewed with the UK IPO to remain in force.
Sipara Limited is listed as the attorney / representative of record for UK trademark UK00914958607 for the mark 'upl Universal Patient Language' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.